- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT01706757
Assessment of Motivity in People Aged 65 to 86 Years
12. oktober 2012 opdateret af: Department of Clinical Research and Innovation
Assessment of Motivity in People Aged 65 to 86 Years : Comparison of a Standard Assessment Versus a Technological Solution
The ability to walk is one of the fundamental attributes of human beings.
However, with advancing age this ability is modified by a combination of physiological and pathological aging.These changes mainly involve an irregularity of the pitch, reducing the length of the stride, instability and a decrease in walking speed (Beauchet et al., 2002).
Tinetti, Speecheley, Ginter (1988, from Ch Wider, F. Vingerhoets, J Bogousslavsky, 2005) show that 20-30% of heathly older fall each year and state that one of these falls, 25% result in injuries with significant effect and 5% a fracture.
In addition to the risk of fracture fear of falling exists in many older people even before a drop in effective (Recommandation of HAS, 2005).In France, about 9 000 deaths of people aged over 65 are associated each year with a fall and this association increases rapidly with advancing age in both sexes.
It is therefore important in terms of public health, learn to recognize the gait disturbance, to prevent and to make adequate assessments to reduce the risk of falls.
Tools exist to assess the risk of falling.
Some are comprehensive but time-consuming and are generally discarded in favour of other simpler tests (test of Tinetti or get up and go test).
However, the listing of these lacks precision, particularly in terms of duration single timer.To overcome these biases, innovative technology solutions seem to be a good way.
In this study, the investigators will use the motorized go-cart developed by INRIA, entitled ANG (for Assisted Navigation Guide), to obtain more reliable and accurate measurements of parameters such as walking speed and direction.
Thus, the investigators set the main objective, to compare a standard evaluation of the process to a technology assessment, in participants aged 65 to 86 years.
And as secondary objectives : evaluate the acceptance of using go-cart ANG in the elderly, develop an index of walking and test the feasibility of detecting a weakness of the knee joint by ANG undetected at clinic.
Studieoversigt
Undersøgelsestype
Interventionel
Tilmelding (Forventet)
30
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
-
Nice, Frankrig, 06000
- Rekruttering
- Centre Mémoire de Ressources et de Recherche
-
Kontakt:
- Julie Piano, Psychologue
- Telefonnummer: 33 (0)4 92 03 47 75
- E-mail: piano/j@chu-nice.fr
-
Kontakt:
- Philippe Robert, MD, PhD
- Telefonnummer: 33 (0)4 92 03 47 70
- E-mail: robert.p@chu-nice.fr
-
Ledende efterforsker:
- Philippe Robert, MD, PhD
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
65 år til 86 år (Ældre voksen)
Tager imod sunde frivillige
Ja
Køn, der er berettiget til at studere
Alle
Beskrivelse
Inclusion Criteria:
- men and women aged between 65 and 86 years
- participants with no locomotor disability hindering the implementation of the protocol
- participants with no global cognitive impairment (MMSE score <24) (Folstein et al. 1975), or arguments in favor of the following diagnoses : probable Alzheimer's disease according to the criteria of the NINCDS-ADRDA, major depressive episode according to DSM-IV-R
- participant with no apathy according to diagnostic criteria for apathy (Robert, Onyike et al. 2009)
- participants recipients of social security
- signature of informed consent.
Exclusion Criteria:
- impossibility of carrying out the experimental protocol because of a mobility impairment
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Forebyggelse
- Tildeling: Randomiseret
- Interventionel model: Crossover opgave
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: with go-cart
conducts exercises with the help of a go-cart
|
conducts exercises with the help of a go-cart
|
|
Ingen indgriben: without go-cart
conduct exercises without go-cart
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Walking speed.
Tidsramme: one day
|
Walking speed. This will be calculated from an exercise where participants will be asked to walk from one point to another of the room according to the instructions set out below. The average speed of walking in technology assessment, will be directly collected by ANG. A comparison of estimated speeds as standard and technology can then be performed. |
one day
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
acceptance of the go-cart
Tidsramme: one day
|
|
one day
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Efterforskere
- Ledende efterforsker: Philippe Robert, Md, PhD, Centre Hospitalier Universitaire de Nice
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart
1. december 2011
Primær færdiggørelse (Forventet)
1. december 2012
Studieafslutning (Forventet)
1. december 2012
Datoer for studieregistrering
Først indsendt
18. juni 2012
Først indsendt, der opfyldte QC-kriterier
12. oktober 2012
Først opslået (Skøn)
15. oktober 2012
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
15. oktober 2012
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
12. oktober 2012
Sidst verificeret
1. juli 2012
Mere information
Begreber relateret til denne undersøgelse
Andre undersøgelses-id-numre
- 11-PP-05
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Assessment of Motivity
-
Bradford Teaching Hospitals NHS Foundation TrustUkendtBeslagsfejlfrekvens | Limningstid pr. beslag | Adhæsive Remnant Index for Type of Bond Failure | Behandlingens længde | Peer Assessment Rating
-
AdventHealthAfsluttetDudoenoscope Assessment ToolForenede Stater
-
University of Southern CaliforniaAfsluttetTotal Body Water AssessmentForenede Stater
-
Edwards LifesciencesAfsluttetHjerteoutput og Preload Assessment | LungevandsvurderingTyskland, Schweiz
-
Wake Forest University Health SciencesAfsluttetSelf Geriatric Assessment Measure (SGAM)Forenede Stater
-
Gözde Nur ErkanKırıkkale UniversityAfsluttetSelvevaluering | OSCE (Objective Structured Clinical Examination) | Instruktørvejledning | Intermediate Life Support | Tandlægestuderende | Peer AssessmentTyrkiet (Türkiye)
-
Pamukkale UniversityTilmelding efter invitationKognitiv vurdering | Elektrokonvulsiv terapi (ECT) | Elektrokonvulsiv Terapi Kognitiv Vurdering (ECCA) | Montreal Cognitive Assessment (MoCA) | Tyrkisk tilpasningTyrkiet (Türkiye)
-
Fondazione I.R.C.C.S. Istituto Neurologico Carlo...University of MilanAfsluttet300 studerende ved University of Milan School of MedicineItalien
-
Prisma Health-UpstateNational Institute on Drug Abuse (NIDA); Clemson UniversityAfsluttetStandard for pleje | Standard of Care + CBT4CBT | Standard of Care + CBT4CBT + RCForenede Stater
-
Nimble Science Ltd.University of Calgary; Lallemand Health SolutionsAfsluttet
Kliniske forsøg med go-cart
-
University of MinnesotaAfsluttet
-
Chang Gung University of Science and TechnologyNational Science and Technology Council, TaiwanAfsluttetSundhedsfremme | Skrøbelighed hos ældre voksneTaiwan
-
Northwestern UniversityAfsluttet
-
University of PennsylvaniaNovartisAktiv, ikke rekrutterende
-
University of North Carolina, Chapel HillNational Heart, Lung, and Blood Institute (NHLBI); University of Kentucky; Child Care Aware of KentuckyAfsluttet
-
Union Hospital, Tongji Medical College, Huazhong...Nanjing Bioheng Biotech Co., Ltd.RekrutteringAutoimmun hæmolytisk anæmi | Evans syndrom | Primær immun trombocytopenisk purpuraKina
-
Institute of Hematology & Blood Diseases Hospital...Hebei Taihe Chunyu Biotechnology Co., LtdRekrutteringPlasmacelleleukæmi | Ultra High Risk MM (UHR-MM), 18-70 år gammel, velegnet til ASCT. Og opfylder nogen af følgende UHR-MM-definitioner | Cytogenetik ultra høj risiko | Primær ildfast | Tidlig progression | Ikke paraosseous ekstramedullær infiltration | R2-ISS-IV /MPSS-IVKina
-
Shanghai Simnova Biotechnology Co.,Ltd.Aktiv, ikke rekrutterende
-
National University Hospital, SingaporeRekrutteringB-celle lymfom refraktærSingapore
-
University of PennsylvaniaAfsluttetEpitelial ovariecancer | Metastatisk bugspytkirtel (duktalt) adenokarcinom | Malignt epitel pleura mesotheliomForenede Stater